<Entry>
<Accession>Q03963</Accession>
        <ProteinName>Interferon-induced,</ProteinName>
        <GeneName>Eif2ak2</GeneName>
        <OS_id>10090</OS_id>
        <ReferenceProteome>None</ReferenceProteome>
        <SubcellularLocation>
<Location>SL-0198</Location>
<Comments>Cytoplasm {ECO:0000250|UniProtKB:P19525}. Nucleus {ECO:0000250|UniProtKB:P19525}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:P19525}.</Comments>
</SubcellularLocation>
<CrossReferences>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q03963</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q61742</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q62026</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>1X48</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>1X49</ID>
</CrossReference>
<CrossReference>
<Database>Pfam</Database>
<ID>PF00035</ID>
</CrossReference>
<CrossReference>
<Database>Pfam</Database>
<ID>PF00069</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS50137</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS00107</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS50011</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS00108</ID>
</CrossReference>
</CrossReferences>
<Function>IFN-induced dsRNA-dependent serine/threonine-protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the innate immune response to viral infection (PubMed:20038207, PubMed:20478537, PubMed:21123651). Inhibits viral replication via the integrated stress response (ISR): EIF2S1/eIF-2-alpha phosphorylation in response to viral infection converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, resulting to a shutdown of cellular and viral protein synthesis, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4 (PubMed:21123651, PubMed:20631127). Exerts its antiviral activity on a wide range of DNA and RNA viruses including west nile virus (WNV), sindbis virus (SV), foot-and-mouth virus (FMDV), semliki Forest virus (SFV) and lymphocytic choriomeningitis virus (LCMV) (PubMed:19264662, PubMed:20585572, PubMed:20631127, PubMed:21994357). Also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation: phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3, and IRS1 (PubMed:19229320, PubMed:23403623). In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity and phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its ubiquitination and proteosomal degradation (By similarity). Either as an adapter protein and/or via its kinase activity, can regulate various signaling pathways (p38 MAP kinase, NF- kappa-B and insulin signaling pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved in the expression of genes encoding pro-inflammatory cytokines and IFNs (PubMed:22948222, PubMed:23392680). Activates the NF-kappa-B pathway via interaction with IKBKB and TRAF family of proteins and activates the p38 MAP kinase pathway via interaction with MAP2K6 (By similarity). Can act as both a positive and negative regulator of the insulin signaling pathway (ISP) (By similarity). Negatively regulates ISP by inducing the inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5A which activates FOXO1, which in turn up-regulates the expression of insulin receptor substrate 2 (IRS2) (By similarity). Can regulate NLRP3 inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and NLRC4 inflammasomes (PubMed:22801494, PubMed:23401008). Plays a role in the regulation of the cytoskeleton by binding to gelsolin (GSN), sequestering the protein in an inactive conformation away from actin (PubMed:22633459). {ECO:0000250|UniProtKB:P19525, ECO:0000269|PubMed:19229320, ECO:0000269|PubMed:19264662, ECO:0000269|PubMed:20038207, ECO:0000269|PubMed:20478537, ECO:0000269|PubMed:20585572, ECO:0000269|PubMed:20631127, ECO:0000269|PubMed:21123651, ECO:0000269|PubMed:21994357, ECO:0000269|PubMed:22633459, ECO:0000269|PubMed:22801494, ECO:0000269|PubMed:22948222, ECO:0000269|PubMed:23392680, ECO:0000269|PubMed:23401008, ECO:0000269|PubMed:23403623}.</Function>
<Interactions>
<Interaction>
<Partner>P35569</Partner>
<IntAct>EBI-2603482</IntAct>
<Score>0.40</Score>
</Interaction>
<Interaction>
<Partner>P35570</Partner>
<IntAct>EBI-2603524</IntAct>
<Score>0.44</Score>
</Interaction>
<Interaction>
<Partner>Q8R4B8</Partner>
<IntAct>EBI-15999088</IntAct>
<Score>0.52</Score>
</Interaction>
<Interaction>
<Partner>Q9EPB4</Partner>
<IntAct>EBI-15999182</IntAct>
<Score>0.40</Score>
</Interaction>
</Interactions>
<OntologyTerms>
<Ontology>GO:0005737</Ontology>
<Ontology>GO:0005829</Ontology>
<Ontology>GO:0005634</Ontology>
<Ontology>GO:0048471</Ontology>
<Ontology>GO:0005524</Ontology>
<Ontology>GO:0003725</Ontology>
<Ontology>GO:0004694</Ontology>
<Ontology>GO:0042802</Ontology>
<Ontology>GO:0004715</Ontology>
<Ontology>GO:0004672</Ontology>
<Ontology>GO:0106310</Ontology>
<Ontology>GO:0034198</Ontology>
<Ontology>GO:0051607</Ontology>
<Ontology>GO:0030968</Ontology>
<Ontology>GO:0045087</Ontology>
<Ontology>GO:0043066</Ontology>
<Ontology>GO:0033689</Ontology>
<Ontology>GO:0017148</Ontology>
<Ontology>GO:0045071</Ontology>
<Ontology>GO:0043065</Ontology>
<Ontology>GO:0032722</Ontology>
<Ontology>GO:0001819</Ontology>
<Ontology>GO:0043410</Ontology>
<Ontology>GO:0051092</Ontology>
<Ontology>GO:1901224</Ontology>
<Ontology>GO:0032874</Ontology>
<Ontology>GO:0046777</Ontology>
<Ontology>GO:0006468</Ontology>
<Ontology>GO:1901532</Ontology>
<Ontology>GO:1902036</Ontology>
<Ontology>GO:1902033</Ontology>
<Ontology>GO:1900225</Ontology>
<Ontology>GO:0035455</Ontology>
<Ontology>GO:0032496</Ontology>
<Ontology>GO:0009636</Ontology>
<Ontology>GO:0009615</Ontology>
<Ontology>GO:0033197</Ontology>
<Ontology>GO:0006412</Ontology>
</OntologyTerms>
<Topology>
        <Type>Unknown</Type>
        <Source>UniProt</Source>
        <Annotation>Sequence Analysis</Annotation>
        </Topology>
<Sequence>MASDTPGFYMDKLNKYRQMHGVAITYKELSTSGPPHDRRFTFQVLIDEKEFPEAKGRSKQEARNAAAKLAVDILDNENKVDCHTSASEQGLFVGNYIGLVNSFAQKKKLSVNYEQCEPNSELPQRFICKCKIGQTMYGTGSGVTKQEAKQLAAKEAYQKLLKSPPKTAGTSSSVVTSTFSGFSSSSSMTSNGVSQSAPGSFSSENVFTNGLGENKRKSGVKVSPDDVQRNKYTLDARFNSDFEDIEEIGLGGFGQVFKAKHRIDGKRYAIKRVKYNTEKAEHEVQALAELNHVNIVQYHSCWEGVDYDPEHSMSDTSRYKTRCLFIQMEFCDKGTLEQWMRNRNQSKVDKALILDLYEQIVTGVEYIHSKGLIHRDLKPGNIFLVDERHIKIGDFGLATALENDGKSRTRRTGTLQYMSPEQLFLKHYGKEVDIFALGLILAELLHTCFTESEKIKFFESLRKGDFSNDIFDNKEKSLLKKLLSEKPKDRPETSEILKTLAEWRNISEKKKRNTC</Sequence>
        <SequenceLength>515</SequenceLength>
        </Entry>